Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004298:Dopamine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D008466:Mechlorethamine / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011458:Prostaglandins E / Q000627:therapeutic use*; D013852:Thiotepa / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011458:Prostaglandins E; D008466:Mechlorethamine; D014750:Vincristine; D004317:Doxorubicin; D013852:Thiotepa; D005472:Fluorouracil; D004298:Dopamine